Objectives: Scoring laboratory polysomnography (PSG) data remains a manual task of visually annotating 3 primary categories: sleep stages, sleep disordered breathing, and limb movements. Attempts to automate this process have been hampered by the complexity of PSG signals and physiological heterogeneity between patients. Deep neural networks, which have recently achieved expert-level performance for other complex medical tasks, are ideally suited to PSG scoring, given sufficient training data. Methods: We used a combination of deep recurrent and convolutional neural networks (RCNN) for supervised learning of clinical labels designating sleep stages, sleep apnea events, and limb movements. The data for testing and training were derived from 10 000 clinical PSGs and 5804 research PSGs. Results: When trained on the clinical dataset, the RCNN reproduces PSG diagnostic scoring for sleep staging, sleep apnea, and limb movements with accuracies of 87.6%, 88.2% and 84.7% on held-out test data, a level of performance comparable to human experts. The RCNN model performs equally well when tested on the independent research PSG database. Only small reductions in accuracy were noted when training on limited channels to mimic at-home monitoring devices: frontal leads only for sleep staging, and thoracic belt signals only for the apnea-hypopnea index. Conclusions: By creating accurate deep learning models for sleep scoring, our work opens the path toward broader and more timely access to sleep diagnostics. Accurate scoring automation can improve the utility and efficiency of in-lab and at-home approaches to sleep diagnostics, potentially extending the reach of sleep expertise beyond specialty clinics.
INTRODUCTION
Common sleep disorders such as sleep apnea, insomnia, and restless legs syndrome impact tens of millions of adults and are significant risk factors for cardiometabolic and neurodegenerative diseases, impaired performance, and decreased quality of life. [1] [2] [3] [4] [5] [6] [7] The population health impact is enormous, including medical and psychiatric morbidity, motor vehicle accidents, decreased work productivity and quality of life, and increased mortality. 7, 8 Timely and accurate diagnosis of sleep disorders is critical to pursue appropriate treatment and improve health outcomes, 9 yet most sleep disorders remain undiagnosed. 10, 11 Recent advances in portable monitoring technology have increased access to sleep diagnostics, yet both at-home and the gold-standard in-lab polysomnography (PSG) still require manual scoring. Previous attempts to automate diagnosis of sleep disorders have generally relied on fewer than 100 PSGs from relatively homogeneous groups of healthy individuals. 12 Models trained on such V C The Author(s) 2018. Published by Oxford University Press on behalf of the American Medical Informatics Association. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contactjournals.permissions@oup.com datasets are not likely to generalize well, because PSG signals vary widely due to differences in demographics, medication effects, sleep conditions, and medical conditions. We address this variability using a data-driven approach based on 79 456 hours of clinical data from 10 000 nights of PSG recording. This real-world data, recorded over 8 years in a clinical sleep laboratory, makes our PSG analysis system robust to physiologic variability between patients. Most prior approaches involve preprocessing and extraction of carefully engineered features before classification. 12 Our system is trained end-toend, directly from labeled signals.
Deep neural networks, fueled by increases in computing power and availability of large labeled datasets, have recently matched the performance of medical experts in complex medical pattern recognition tasks such as visual diagnosis of dermatologic lesions 13 and diabetic retinopathy. 14 In this paper, we outline the development of a Recurrent Convolutional Neural Network (RCNN) that matches the performance of sleep experts in annotating overnight PSGs. No prior study has simultaneously addressed all 3 key types of PSG information extracted by expert scorers: sleep stages, respiratory events, and limb movements. Our system uses a unified deep network architecture (RCNN) to accomplish all 3 tasks. Prior work, for comparison, uses mainly small datasets, and mainly of healthy adults.
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METHODS
Description of deep neural network development
Deep learning algorithms such as multi-layer perceptrons, convolutional neural networks (CNN), and recurrent neural networks (RNN) have been successfully applied to many domains to solve challenging tasks. The most basic computation unit in neural networks is a perceptron which performs linear combinations of input features followed by a nonlinear transformation. The standard deep neural networks (DNN) consist of multiple layers of perceptrons, which all fully connected across consecutive layers. To avoid dense connections in DNN, CNNs introduces local connections and parameter sharing through convolution operations, which demonstrated numerous successes in computer vision application such as object recognition. RNNs are another extension of DNN that are suitable for modeling sequential data such as natural language text and time series. A detailed overview of various deep learning models for analyzing medical data can be found at Xiao et al. 31 Here, we briefly describe the rationale of designing and developing deep neural networks for analysis of clinical sleep data. We initially used classical machine learning algorithms such as logistic regression and random forest directly on expert defined features. However, the resulting performance is not very high as shown in Supplementary  Table S2 . Also, it often takes a lot of time and effort to carefully develop expert defined features, since it requires domain expertise. On the other hand, deep neural networks, such as a convolutional neural network, can extract better features and then pass those learned features in a recurrent neural network to detect sleep stages over time.
Dataset
The datasets used in this paper are from 2 sources: The Massachusetts General Hospital (MGH) sleep laboratory and the Sleep Heart Health Study (SHHS), summarized in Supplementary 
Classification targets
Different target labels are modeled for the 3 scoring tasks. 
Data preparation
EEG data in PSG consists of signals from 6 channels, ie F3, F4, C3, C4, O1 and O2, each referenced to the contralateral mastoid.
In Supplementary Figure S1 , we show a schematic of the locations of the electrodes. While the MGH dataset has 6 electrodes, the SHHS dataset has only 2 EEG electrodes (C3, C4). Both MGH and SHHS datasets contain the following respiratory signals: chest belt, abdomen belt, SaO2 (oximetry), and airflow. The pressure transducer airflow (PTAF) present in the diagnosis phase of MGH set is not used in the final model, since including it yields no significant performance improvement (data not shown). The left and right anterior tibialis (LAT and RAT) EMG channels for limb movement detection are present in MGH dataset only. The sampling frequency of the data is 200Hz. We use both raw waveform and spectrogram representations of the data as inputs for our models. For the spectrogram representation of EEG and EMG data, we segment each 30-second epoch into 29 subepochs of 2 seconds duration with 1-second overlap. For each 2-second subepoch, we use Thomson's multitaper method to estimate the power spectral density (PSD), with the following parameters: window length, T ¼ 2s, time-bandwidth product, TW ¼ 3, number of tapers K ¼ 5. [32] [33] [34] For respiratory signals, the parameters
We split our datasets into train and test sets using 90/10 percentage splits of the original cohorts. Model performance is evaluated on the test sets. There is no overlap between test and training sets. As the MGH dataset has 10 000 PSGs, the train set consists of 9000 cases, and the test set consists of 1000 cases. The SHHS dataset has 5804 PSGs, so the train set has 5224 and the test set has 580 cases.
Sample selection
The sleep staging task has five different target classes: N1, N2, N3, R and W. These classes have approximately 19 million, 75 million, 22 million, 21 million, and 18 million 30 second epochs from the MGH dataset for N1-N3, R and W, respectively. Similarly, the SHHS dataset consists of approximately 11 million, 46 million, 9 million, 8 million, and 11 million, 30 second epochs for N1-N3, R and W, respectively. For sleep apnea detection, the MGH dataset contains approximately 2 million respiratory events. Similarly, the SHHS dataset has about 650 000 apnea events. For limb movement detection, the MGH data has approximately 2.7 million limb movement events.
Training algorithms
We combine two different primary types of neural networks in all experiments. We use a convolutional neural network (CNN) and recurrent neural network (RNN). We refer to the combination of these models as RCNN. The combination of CNN with RNN enables us to extract features from raw data using the CNN and to model longrange temporal dependencies present in the data with the RNN. The CNN module contains 2 filter sizes (100 and 200 dimensions) to capture patterns across different time scales, which we empirically find to have better performance than just a single filter size.
The details of the RCNN architecture used in our experiments are presented in Supplementary Figure S1 . For sleep staging, the input for the CNN is the spectrogram representation of the EEG signal. Similarly, for AHI detection, we provide 60 second blocks of respiratory signal data or spectrogram representation of these channels. For the limb movement detection task, we provide 60 second blocks of EMG (LAT, RAT) raw waveform or spectrogram representation to the CNN.
Our models are trained using backpropagation. We use crossentropy as the loss function to train the models. The categorical cross-entropy loss is given by
where y is the predicted probability distribution and y' is the true distribution.
We adopt batch normalization (BN) after each convolution and before activation. 35 We initialize the weights as in 36 and train all neural networks from scratch. We use stochastic gradient descent (SGD) with a mini-batch size of 100. The learning rate starts from 0.1 and is divided by 10 when the error plateaus. We use a weight decay of 0.0001 and a momentum of 0.9. We perform 50 iterations of random search over a set of parameter choices for hyperparameter tuning. All models are implemented using PyTorch (http://pytorch.org/). All experiments are conducted on a server with Intel Xeon E5-2640, 256GB RAM, four NVidia Titan X GPU, and CUDA 8.0.
Scoring algorithms
Given an input sample, the trained model outputs a probability distribution over the possible target classes. In the sleep stage detection model, the model provides the probability distribution over the 5 AASM sleep stages. Similarly, in the AHI and LMI detection tasks, the model provides a probability that the sample is an apnea or a limb movement event. We use a sliding window to combine adjacent one-second output decisions to define individual apnea or limbmovement events. By merging adjacent one second outputs, we combine them into a single detected apnea or limb movement event. This allows us to compare annotations from the RCNN directly with those from experts, since experts label entire events (eg by marking the beginning and ending of an apnea) rather than independently labeling 2 second intervals. Expressing detections as single merged events also allows us to calculate the clinically relevant measures of apnea and limb movement abnormality, AHI (apnea hypopnea index) and LMI (limb movement index), which are the number of apneas or limb movements, respectively, per hour of sleep.
Evaluation
To measure performance on sleep stage classification, we use the overall classification accuracy, and classification accuracy broken down by stage, shown as a confusion matrix. Element (i, j) of each confusion matrix represents the empirical probability of predicting class j given that the ground truth (expert label) is class i.
To measure performance on apnea classification, we use the correlation value (r 2 ) between the algorithm-predicted AHI and the AHI computed from expert-scored PSGs, where AHI ¼ (Apnea þ Hypopnea events)/hours of sleep. To measure performance in the limb movement detection task, we calculate the correlation value (r 2 ) between the algorithm-predicted LMI and the LMI based on expert scoring of PSGs, where LMI ¼ (number of leg movement events)/hours of sleep.
Cross dataset experiments
We evaluate our models for sleep stage detection and apnea detection in both the MGH and the SHHS datasets in the supplemental material (Supplementary Tables S2-S4 ). In Supplementary Table S2 we present the accuracy of models trained using MGH data and tested on SHHS, trained using SHHS and tested using MGH, and trained using the combination of MGH and SHHS and tested on MGH or on SHHS. We also show the test performance of the MGH model using only frontal channels to simulate sleep monitoring using home monitoring devices. Supplementary Table S3 shows the AHI estimation in different test-train and limited-channel contexts. Unlike multi-channel PSG data, home monitoring sensors often come from a single channel such as abdomen or chest belt. To simulate home monitoring, we assess how well models trained on a single channel (either abdomen or chest belt) perform in comparison to models given access to multi-channel PSG data. Finally, Supplementary Table S4 shows model performance for limb movement detection on MGH data.
RESULTS
Our data consisted of 10 000 clinical PSGs performed at the Massachusetts General Hospital Sleep Laboratory (MGH data), split into 9000 training and validation PSGs and 1000 PSGs held out for testing.
We utilized a convolutional neural network (CNN) to model the local spatiotemporal characteristics of 30-second PSGs, combined with a recurrent neural network (RNN) to model long-range temporal dependencies. Figure 1 shows the RCNN system architecture. Our dataset was composed of PSGs labeled by certified sleep technologists, following the American Academy of Sleep Medicine (AASM) standards. 37 The RCNN was trained to use 6 EEG channels to assign to each 30-second PSG to one of 5 sleep stages: awake (W), rapid eye movement (REM) sleep (R), and non-REM stages 1-3 (N1-N3). In addition, the RCNN was trained to use 5 respiratory channels to detect apnea events, quantified as the apnea-hypopnea index (AHI; events/hour of sleep), and limb movement events using the leg EMG channels, quantified as the limb movement index (LMI; events/hour of sleep). For sleep staging, the RCNN achieved an overall accuracy of 87.5% [84.2, 90.9], which compares favorably to human expert performance 38, 39 ( Figure 2a) . Also RCNN significantly outperformed classical machine learning methods such as logistic regression (accuracy 69.34%) and random forest (accuracy 74.52%) as shown in Supplementary Table S2 . Besides lower performance in terms of accuracy, classical machine learning methods require expert-defined features, which are not always available such as for AHI and LMI prediction. AHI inferred by the RCNN strongly correlated with expert scoring (r 2 ¼ 0.85) (Figure 2b ). Converting AHI values into standard clinical categories of mild, moderate and severe disease, the RCNN achieved an overall diagnostic accuracy of 88.2% [84.7, 91.4] ( Table 1) . Importantly, when the apnea severity inferred by the RCNN disagreed with experts, misclassification was mainly to an adjacent severity category (Figure 2c) . We used the desaturation criteria (rather than arousal criteria) for calculating AHI events, as inter-rater reliability is higher for desaturation criteria. 40 The predicted LMI correlated strongly with expert scoring (r 2 ¼0.79; Figure 2d ). This level of performance is comparable with expert performance, though annotation performance of limb movements is less well studied, particularly in subjects with concurrent sleep apnea. 41 To further validate the RCNN's generalization capability, we evaluated the performance of sleep staging and sleep apnea detection on an independent set of publicly available PSGs (SHHS data; n ¼ 5804; www.sleepdata.org). The SHHS utilizes limited-channel EEG data (2 central channels), and respiratory effort, airflow and oximetry channels, but does not include limb electromyogram signals (EMG). First, we tested the MGH-trained RCNN on 1000 randomly selected PSGs from SHHS. To enable testing on SHHS, we first retrained the sleep staging RCNN on the MGH training data while allowing access to only 2 central EEG channels to mimic the SHHS EEG configuration. To compare generalization capabilities of RCNNs trained with real-world clinical PSG data (MGH) vs standardized clinical trial data (SHHS), we evaluated sleep staging and apnea detection in cross-training experiments: train on MGH data, test on both MGH and SHHS data; then train on SHHS data, and test on MGH and SHHS data. In all experiments, the PSG sets used for training and testing are kept constant. Results are shown in Table 1 (with additional experiments shown in Supplementary Tables S2-S4) . In all cases, models trained with MGH data performed well on test sets from both MGH and SHHS, confirming the importance and sufficiency of large heterogeneous datasets, even when they derive from routine clinical practice settings, for robust model training.
We next investigated the features learned by the RCNN for scoring sleep stages (Figure 3a) , AHI (Figure 3b) , and LMI (Figure 3c ), using t-SNE (t-distributed Stochastic Neighbor Embedding). 42 Each point represented a signal segment projected from the 124-dimensional high-dimensional output of the RCNN's last hidden layer onto a plane. The RCNN has learned to form well-separated clusters of points from signals belonging to the same annotation classes.
DISCUSSION
Our results demonstrate human-level performance of deep learning algorithms trained on large PSG datasets to replicate the primary categories of scoring: stages, sleep apnea, and limb movements. Our large PSG sample size allows cross-validation steps during training (to minimize the risk of model overfitting), and testing on an independent, held-out set of 1000 PSGs to obtain unbiased estimates of performance. The clinical heterogeneity and lack of special selection or exclusion of cases supports the generalization of performance when trained on the MGH set and tested on the independent research cohort of the SHHS. External validation of this kind is crucial to address a common criticism of scoring automation: will the algorithm performance be robust when applied broadly? Our results also address one form of conventional wisdom that careful standardization of PSG recording conditions and homogeneity of patient characteristics are critical to obtaining generalizable algorithms. Our results suggest that, given sufficiently large datasets, training on real-world data can yield human level performance and generalize to standardized data sets (such as SHHS). The capacity to generalizability is a pre-requisite for algorithm deployment in realworld settings, especially in medical diagnostics that routinely encounter heterogeneous pathophysiology. Further, the availability of clinical datasets obtained in routine practice in principle far exceeds that of research studies, and our results provide motivation to utilize such "in-hand" data to develop predictive algorithms.
Feature selection is another key problem in the application of supervised machine learning. Although it is natural to assume that Note: Accuracy is measured as the percent agreement between labels inferred by the algorithm and expert labels. For apnea and limb movement detection, accuracy is measured both by the correlation (r 2 ) with expert scores of the algorithm's estimate of the number of events per hour of sleep (apneahypopnea index (AHI), or limb movement index (LMI)), and by the expert-algorithm agreement of regarding categorization of the event burden as mild, moderate or severe. Cohen's Kappa is provided as a complementary measure of accuracy which takes into account the probability of agreement occurring by chance.
features informed by experts with domain knowledge, sometimes described as "feature engineering," ought to be an important component in developing machine learning algorithms, our results shows that deep learning models can learn better features than human in this specific task. Specifically, we train our deep learning algorithms using generic features, as well as direct time series data, and obtain humanlevel scoring accuracy. The advantages to this approach include the minimization of bias, as well as reduced burden on human capital, which can be spent more efficiently on preparation and interpretation.
In addition to automation of in-lab scoring, the accuracy of portable sleep recording systems stand to directly benefit from reliable and robust algorithms. Because portable systems reach a far larger audience, whether clinical or consumer is in nature, robust and scalable scoring is necessary, if only to accommodate the increased scale. The minor reduction in accuracy when moving from 6-to 2-channel EEG for staging, and from 5 respiratory channels to 1 for sleep apnea, is still on par with the level of accuracy attained by experts. These results suggest that accurate automated analysis of sleep stages and apnea is attainable with limited-channel devices such as those available for at-home use. Improvement of classification with limited channels has important implications for clinical diagnostics such as home sleep apnea testing kits, 43 as well as consumer facing devices, 44 which the Food and Drug Administration is showing increasing willingness to consider for some medical uses (for example, arrhythmia detection). 45 In summary, our deep network is accurate and scalable, and can be deployed on multi-channel (eg in-lab PSG) or limited channel (eg portable) acquisition systems. The potential for substantial clinical impact includes broadening the reach of clinical sleep medicine, augmenting clinical decision-making for sleep specialists, and improving the accuracy and reliability of at-home portable systems. Further work should focus on integrating this new technology into specific monitoring devices and optimizing performance in real-world clinical settings. The ability to automate overnight PSG scoring with the accuracy of a sleep specialist has the potential to expand access to essential medical care. 
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